The recognition of biomaterials: Pattern recognition of medical polymers and their adsorbed biomolecules

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 9, 2013, Pages 2740-2752

  Love, Ryan J ^a   Jones, Kim S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

biomaterial; leukocyte activation; pattern recognition; scavenger receptors; toll like receptors

Indexed keywords

BIOMEDICAL MATERIAL; HYDROPHOBIC BIOMATERIALS; MATERIAL SCIENTISTS; MEDICAL MATERIALS; PATTERN RECOGNITION RECEPTORS; SCAVENGER RECEPTOR; SURFACE PROTEINS; TOLL-LIKE RECEPTORS;

BIOCHEMISTRY; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMEDICAL ENGINEERING; PATTERN RECOGNITION; PATTERN RECOGNITION SYSTEMS; PROTEINS;

FUNCTIONAL POLYMERS;

BIOMATERIAL; INTEGRIN; MEMBRANE PROTEIN; POLYMER; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR;

ARTICLE; BIOCOMPATIBILITY; LEUKOCYTE;

BIOMATERIAL; LEUKOCYTE ACTIVATION; PATTERN RECOGNITION; SCAVENGER RECEPTORS; TOLL-LIKE RECEPTORS;

ADSORPTION; BIOCOMPATIBLE MATERIALS; COMPLEMENT ACTIVATION; INFLAMMATION; INTEGRINS; LEUKOCYTES; MATERIALS TESTING; MODELS, IMMUNOLOGICAL; OPSONIN PROTEINS; POLYMERS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84880629923     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34577     Document Type: Article

References (164)

1. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E,. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005; 29: 34-48.
2. Fernandez-Cossio S, Castano-Oreja MT,. Biocompatibility of two novel dermal fillers: Histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg 2006; 117: 1789-1796.
3. Vroman L, Adams AL, Fischer GC, Munoz PC,. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 1980; 55: 156-159.
4. Norde W, Macritchie F, Nowicka G, Lyklema J,. Protein adsorption at solid liquid interfaces-Reversibility and conformation aspects. J Colloid Interface Sci 1986; 112: 447-456.
5. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ,. Mediation of biomaterial-cell interactions by adsorbed proteins: A review. Tissue Eng 2005; 11 (1-2): 1-18.
6. Anderson JM, Rodriguez A, Chang DT,. Foreign body reaction to biomaterials. Semin Immunol 2008; 20: 86-100.
7. Anderson JM, Bonfield TL, Ziats NP,. Protein adsorption and cellular adhesion and activation on biomedical polymers. Int J Artif Organs 1990; 13: 375-382.
8. Pankowsky DA, Ziats NP, Topham NS, Ratnoff OD, Anderson JM,. Morphologic characteristics of adsorbed human plasma-proteins on vascular grafts and biomaterials. J Vasc Surg 1990; 11: 599-606.
9. Guidoin R, Snyder R, Martin L, Botzko K, Marois M, Awad J, King M, Domurado D, Bedros M, Gosselin C,. Albumin coating of a knitted polyester arterial prosthesis: An alternative to preclotting. Ann Thorac Surg 1984; 37: 457-465.
10. Kottke-Marchant K, Anderson JM, Umemura Y, Marchant RE,. Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. Biomaterials 1989; 10: 147-155.
11. Tang LP, Eaton JW,. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147-2156.
12. Tang LP, Eaton JW,. Adsorbed fibrinogen triggers acute inflammatory responses to biomaterials. Clin Res 1993; 41: A164-A164.
13. Tang LP, Lucas AH, Eaton JW,. Inflammatory responses to implanted polymeric biomaterials-Role of surface-adsorbed immunoglobulin-G. J Lab Clin Med 1993; 122: 292-300.
14. Hamad OA, Ekdahl KN, Nilsson B,. Non-proteolytically activated C3 promotes binding of activated platelets and platelet-derived microparticles to leukocytes via CD11b/CD18. Immunobiology 2012; 217: 1191-1191.
15. Ueda T, Rieu P, Brayer J, Arnaout MA,. Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18). Proc Natl Acad Sci USA 1994; 91: 10680-10684.
16. Sheng N, Fairbanks MB, Heinrikson RL, Canziani G, Chaiken IM, Mosser DM, Zhang H, Colman RW,. Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1. Blood 2000; 95: 3788-3795.
17. Altieri DC, Plescia J, Plow EF,. The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion. J Biol Chem 1993; 268: 1847-1853.
18. Ugarova TP, Solovjov DA, Zhang L, Loukinov DI, Yee VC, Medved LV, Plow EF,. Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen. J Biol Chem 1998; 273: 22519-22527.
19. Altieri DC, Edgington TS,. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem 1988; 263: 7007-7015.
20. Altieri DC, Morrissey JH, Edgington TS,. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988; 85: 7462-7466.
21. Plescia J, Altieri DC,. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 1996; 319 (Part 3): 873-879.
22. Ratner BD,. The biocompatibility manifesto: biocompatibility for the twenty-first century. J Cardiovasc Transl Res 2011; 4: 523-527.
23. Volle JM, Tolleshaug H, Berg T,. Phagocytosis and chemiluminescence response of granulocytes to monodisperse latex particles of varying sizes and surface coats. Inflammation 2000; 24: 571-582.
24. Peiser L, Mukhopadhyay S, Gordon S,. Scavenger receptors in innate immunity. Curr Opin Immunol 2002; 14: 123-128.
25. Mukhopadhyay S, Gordon S,. The role of scavenger receptors in pathogen recognition and innate immunity. Immunobiology 2004; 209 (1-2): 39-49.
26. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S,. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005; 182: 1-15.
27. Pluddemann A, Neyen C, Gordon S,. Macrophage scavenger receptors and host-derived ligands. Methods 2007; 43: 207-217.
28. Kobzik L,. Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors. J Immunol 1995; 155: 367-376.
29. Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, Suzuki H, Kodama T, Tryggvason K, Koziel H, Kobzik L,. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med 1999; 189: 1497-1506.
30. Arredouani MS, Palecanda A, Koziel H, Huang YC, Imrich A, Sulahian TH, Ning YY, Yang Z, Pikkarainen T, Sankala M, Vargas SO, Takeya M, Tryggvason K, Kobzik L. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 2005; 175: 6058-6064.
31. Seong SY, Matzinger P,. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469-478.
32. Medzhitov R, Janeway C, Jr., Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173: 89-97.
33. Janeway CA Jr, Medzhitov R,. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
34. Akira S, Uematsu S, Takeuchi O,. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
35. Takeuchi O, Akira S,. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
36. Bianchi ME,. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
37. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S,. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752.
38. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M,. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.
39. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ,. Toll-like receptor-2 mediates lipopolysaccharide- induced cellular signalling. Nature 1998; 395: 284-288.
40. Hampton RY, Golenbock DT, Penman M, Krieger M, Raetz CR,. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991; 352: 342-344.
41. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN,. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001; 166: 574-581.
42. Cornelius RM, Archambault JG, Berry L, Chan AKC, Brash JL,. Adsorption of proteins from infant and adult plasma to biomaterial surfaces. J Biomed Mater Res 2002; 60: 622-632.
43. Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B,. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 2002; 168: 5786-5791.
44. Andersson J, Ekdahl KN, Lambris JD, Nilsson B,. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005; 26: 1477-1485.
45. Yu D, Ghosh R,. Method for studying immunoglobulin G binding on hydrophobic surfaces. Langmuir 2010; 26: 924-929.
46. Aida Y, Onoue K,. Triggering of the superoxide generation of macrophages by crosslinking of Fc gamma receptor. J Biochem 1984; 95: 1067-1072.
47. Walivaara B, Askendal A, Lundstrom II, Tengvall P,. Imaging of the early events of classical complement activation using antibodies and atomic force microscopy. J Colloid Interface Sci 1997; 187: 121-127.
48. Reid KB, Porter RR,. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J 1976; 155: 19-23.
49. Perkins SJ, Nealis AS,. The quaternary structure in solution of human complement subcomponent C1r2C1s2. Biochem J 1989; 263: 463-469.
50. Cooper NR,. The classical complement pathway: Activation and regulation of the first complement component. Adv Immunol 1985; 37: 151-216.
51. Nilsson UR,. Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol Immunol 2001; 38 (2-3): 151-160.
52. Governa M, Valentino M, Visona I, Marchiseppe I, Lo Martire N,. Activation of the alternative complement pathway and generation of stimulating factors for granulocytes by glass fibers. Cell Biol Toxicol 1988; 4: 187-197.
53. Hed J, Johansson M, Lindroth M,. Complement activation according to the alternate pathway by glass and plastic surfaces and its role in neutrophil adhesion. Immunol Lett 1984; 8: 295-299.
54. Wettero J, Askendal A, Bengtsson T, Tengvall P,. On the binding of complement to solid artificial surfaces in vitro. Biomaterials 2002; 23: 981-991.
55. Andersson J, Larsson R, Richter R, Ekdahl KN, Nilsson B,. Binding of a model regulator of complement activation (RCA) to a biomaterial surface: Surface-bound factor H inhibits complement activation. Biomaterials 2001; 22: 2435-2443.
56. Engberg AE, Sandholm K, Bexborn F, Persson J, Nilsson B, Lindahl G, Ekdahl KN,. Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. Biomaterials 2009; 30: 2653-2659.
57. Gorbet MB, Sefton MV,. Complement inhibition reduces material-induced leukocyte activation with PEG modified polystyrene beads (Tentagel (TM)) but not polystyrene beads. J Biomed Mater Res A 2005; 74: 511-522.
58. Nilsson B, Larsson R, Hong J, Elgue G, Ekdahl KN, Sahu A, Lambris JD,. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998; 92: 1661-1667.
59. Schmidt S, Haase G, Csomor E, Lutticken R, Peltroche-Llacsahuanga H,. Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested. J Biomed Mater Res Part A 2003; 66: 491-499.
60. McNally AK, Anderson JM,. Complement C3 participation in monocyte adhesion to different surfaces. Proc Natl Acad Sci USA 1994; 91: 10119-10123.
61. Brash JL, Lyman DJ,. Adsorption of plasma proteins in solution to uncharged, hydrophobic polymer surfaces. J Biomed Mater Res 1969; 3: 175-189.
62. Keselowsky BG, Collard DM, Garcia AJ,. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. J Biomed Mater Res A 2003; 66: 247-259.
63. Sivaraman B, Fears KP, Latour RA,. Investigation of the effects of surface chemistry and solution concentration on the conformation of adsorbed proteins using an improved circular dichroism method. Langmuir 2009; 25: 3050-3056.
64. Barbucci R, Lamponi S, Magnani A,. Fibrinogen conformation and platelet reactivity in relation to material-blood interaction: Effect of stress hormones. Biomacromolecules 2003; 4: 1506-1513.
65. Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, Plow EF, Degen JL,. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113: 1596-1606.
66. Garcia AJ,. Get a grip: Integrins in cell-biomaterial interactions. Biomaterials 2005; 26: 7525-7529.
67. Tang LP, Ugarova TP, Plow EF, Eaton JW,. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996; 97: 1329-1334.
68. Tang LP, Eaton JW,. Inflammatory responses to biomaterials. Am J Clin Pathol 1995; 103: 466-471.
69. Al-Saffar N, Iwaki H, Revell PA,. Direct activation of mast cells by prosthetic biomaterial particles. J Mater Sci Mater Med 1998; 9: 849-853.
70. Thevenot PT, Baker DW, Weng H, Sun MW, Tang L,. The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials 2011; 32: 8394-8403.
71. Orenstein SB, Saberski ER, Klueh U, Kreutzer DL, Novitsky YW,. Effects of mast cell modulation on early host response to implanted synthetic meshes. Hernia 2010; 14: 511-516.
72. Zdolsek J, Eaton JW, Tang L,. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 2007; 5: 31.
73. Rezzani R, Rodella L, Tartaglia GM, Paganelli C, Sapelli P, Bianchi R,. Mast cells and the inflammatory response to different implanted biomaterials. Arch Histol Cytol 2004; 67: 211-217.
74. Tang L, Jennings TA, Eaton JW,. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci USA 1998; 95: 8841-8846.
75. Anderson JM,. Biological responses to materials. Ann Rev Mater Res 2001; 31: 81-110.
76. McNally AK, Anderson JM,. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995; 147: 1487-1499.
77. McNally AK, Anderson JM,. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 2002; 160: 621-630.
78. Jenney CR, DeFife KM, Colton E, Anderson JM,. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-modified surfaces in vitro. Student Research Award in the Master's Degree Candidate Category, 24th Annual Meeting of the Society for Biomaterials, San Diego, CA, April 22-26, 1998. J Biomed Mater Res 1998; 41: 171-184.
79. McNally AK, Jones JA, Macewan SR, Colton E, Anderson JM,. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J Biomed Mater Res A 2008; 86: 535-543.
80. McNally AK, Macewan SR, Anderson JM,. alpha subunit partners to beta1 and beta2 integrins during IL-4-induced foreign body giant cell formation. J Biomed Mater Res A 2007; 82: 568-574.
81. Fraser I, Hughes D, Gordon S,. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993; 364: 343-346.
82. Bowie A, O'Neill LA,. The interleukin-1 receptor/Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000; 67: 508-514.
83. Babensee JE,. Interaction of dendritic cells with biomaterials. Semin Immunol 2008; 20: 101-108.
84. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF III,. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276: 10229-10233.
85. Lee J, Sohn JW, Zhang Y, Leong KW, Pisetsky D, Sullenger BA,. Nucleic acid-binding polymers as anti-inflammatory agents. Proc Natl Acad Sci USA 2011; 108: 14055-14060.
86. Chen H, Li P, Yin Y, Cai X, Huang Z, Chen J, Dong L, Zhang J,. The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion. Biomaterials 2010; 31: 8172-8180.
87. Otterlei M, Ostgaard K, Skjak-Braek G, Smidsrod O, Soon-Shiong P, Espevik T,. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991; 10: 286-291.
88. Yang D, Jones KS,. Effect of alginate on innate immune activation of macrophages. J Biomed Mater Res Part A 2009; 90: 411-418.
89. Otterlei M, Sundan A, Skjak-Braek G, Ryan L, Smidsrod O, Espevik T,. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: Characterization of binding and tumor necrosis factor alpha induction. Infect Immun 1993; 61: 1917-1925.
90. Flo TH, Ryan L, Latz E, Takeuchi O, Monks BG, Lien E, Halaas O, Akira S, Skjak-Braek G, Golenbock DT, Espevik T. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 2002; 277: 35489-35495.
91. Tamayo I, Irache JM, Mansilla C, Ochoa-Reparaz J, Lasarte JJ, Gamazo C,. Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation. Clin Vaccine Immunol 2010; 17: 1356-1362.
92. Maitra R, Clement CC, Crisi GM, Cobelli N, Santambrogio L,. Immunogenecity of modified alkane polymers is mediated through TLR1/2 activation. PLoS One 2008; 3: e2438.
93. Grandjean-Laquerriere A, Tabary O, Jacquot J, Richard D, Frayssinet P, Guenounou M, Laurent-Maquin D, Laquerriere P, Gangloff S,. Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles. Biomaterials 2007; 28: 400-404.
94. Shokouhi B, Coban C, Hasirci V, Aydin E, Dhanasingh A, Shi N, Koyama S, Akira S, Zenke M, Sechi AS,. The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials 2010; 31: 5759-5771.
95. Goldstein JL, Ho YK, Basu SK, Brown MS,. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333-337.
96. Granucci F, Petralia F, Urbano M, Citterio S, Di Tota F, Santambrogio L, Ricciardi-Castagnoli P,. The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood 2003; 102: 2940-2947.
97. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM,. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol 2003; 170: 2302-2309.
98. Baker DP, Vanlenten BJ, Fogelman AM, Edwards PA, Kean C, Berliner JA,. Ldl, scavenger, and beta-vldl receptors on aortic endothelial-cells. Arteriosclerosis 1984; 4: 248-255.
99. Tanner FC, Noll G, Boulanger CM, Luscher TF,. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary-arteries-Role of scavenger receptor and endothelium-derived nitric-oxide. Circulation 1991; 83: 2012-2020.
100. Vanberkel TJC, Derijke YB, Kruijt JK,. Different fate invivo of oxidatively modified low-density-lipoprotein and acetylated low-density- lipoprotein in rats-Recognition by various scavenger receptors on kupffer and endothelial liver-cells. J Biol Chem 1991; 266: 2282-2289.
101. Adachi H, Tsujimoto M, Arai H, Inoue K,. Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem 1997; 272: 31217-31220.
102. Daugherty A, Cornicelli JA, Welch K, Sendobry SM, Rateri DL,. Scavenger receptors are present on rabbit aortic endothelial cells in vivo. Arteriosclerosis Thrombosis Vascular Biol 1997; 17: 2369-2375.
103. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, Takahashi K, Shichiri M, Horiuchi S,. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 1995; 230: 408-415.
104. Paresce DM, Ghosh RN, Maxfield FR,. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1996; 17: 553-565.
105. Itabe H,. Oxidized low-density lipoproteins: What is understood and what remains to be clarified. Biol Pharm Bull 2003; 26: 1-9.
106. Horiuchi S, Unno Y, Usui H, Shikata K, Takaki K, Koito W, Sakamoto Y, Nagai R, Makino K, Sasao A, Wada J, Makino H. Pathological roles of advanced glycation end product receptors SR-A and CD36. Ann NY Acad Sci 2005; 1043: 671-675.
107. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996; 382: 685-691.
108. Bowdish DM, Gordon S,. Conserved domains of the class A scavenger receptors: Evolution and function. Immunol Rev 2009; 227: 19-31.
109. Hughes DA, Fraser IP, Gordon S,. Murine macrophage scavenger receptor: In vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol 1995; 25: 466-473.
110. Elomaa O, Kangas M, Sahlberg C, Tuukkanen J, Sormunen R, Liakka A, Thesleff I, Kraal G, Tryggvason K,. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 1995; 80: 603-609.
111. van der Laan LJ, Dopp EA, Haworth R, Pikkarainen T, Kangas M, Elomaa O, Dijkstra CD, Gordon S, Tryggvason K, Kraal G,. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999; 162: 939-947.
112. van der Laan LJ, Kangas M, Dopp EA, Broug-Holub E, Elomaa O, Tryggvason K, Kraal G,. Macrophage scavenger receptor MARCO: In vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett 1997; 57 (1-3): 203-208.
113. Doyle SE, O'Connell RM, Miranda GA, Vaidya SA, Chow EK, Liu PT, Suzuki S, Suzuki N, Modlin RL, Yeh WC, Lane TF, Cheng G. Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 2004; 199: 81-90.
114. Mukhopadhyay S, Peiser L, Gordon S,. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype. J Leukoc Biol 2004; 76: 577-584.
115. Grolleau A, Misek DE, Kuick R, Hanash S, Mule JJ,. Inducible expression of macrophage receptor Marco by dendritic cells following phagocytic uptake of dead cells uncovered by oligonucleotide arrays. J Immunol 2003; 171: 2879-2888.
116. Becker M, Cotena A, Gordon S, Platt N,. Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response. Eur J Immunol 2006; 36: 950-960.
117. Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, Keshi H, Sakai Y, Fukuoh A, Sakamoto T, Itabe H, Suzutani T, Ogasawara M, Yoshida I, Wakamiya N. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J Biol Chem 2001; 276: 44222-44228.
118. Jiang Y, Oliver P, Davies KE, Platt N,. Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J Biol Chem 2006; 281: 11834-11845.
119. Lim DJ, Antipenko SV, Anderson JM, Jaimes KF, Viera L, Stephen BR, Bryant SM, Yancey BD, Hughes KJ, Cui W, Thompson JA, Corbett JA, Jun HW. Enhanced rat islet function and survival in vitro using a biomimetic self-assembled nanomatrix gel. Tissue Eng Part A 2011; 17 (3-4): 399-406.
120. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386: 292-296.
121. Robbins AK, Horlick RA,. Macrophage scavenger receptor confers an adherent phenotype to cells in culture. Biotechniques 1998; 25: 240-244.
122. Pikkarainen T, Brannstrom A, Tryggvason K,. Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes. J Biol Chem 1999; 274: 10975-10982.
123. Peiser L, De Winther MP, Makepeace K, Hollinshead M, Coull P, Plested J, Kodama T, Moxon ER, Gordon S,. The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun 2002; 70: 5346-5354.
124. Zhu FG, Reich CF, Pisetsky DS,. The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Immunology 2001; 103: 226-234.
125. Kim WS, Ordija CM, Freeman MW,. Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A. Biochem Biophys Res Commun 2003; 310: 542-549.
126. Cotena A, Gordon S, Platt N,. The class A macrophage scavenger receptor attenuates CXC chemokine production and the early infiltration of neutrophils in sterile peritonitis. J Immunol 2004; 173: 6427-6432.
127. Ozeki Y, Tsutsui H, Kawada N, Suzuki H, Kataoka M, Kodama T, Yano I, Kaneda K, Kobayashi K,. Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. Microb Pathog 2006; 40: 171-176.
128. Jozefowski S, Arredouani M, Sulahian T, Kobzik L,. Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J Immunol 2005; 175: 8032-8041.
129. Jozefowski S, Kobzik L,. Scavenger receptor A mediates H2O2 production and suppression of IL-12 release in murine macrophages. J Leukoc Biol 2004; 76: 1066-1074.
130. Hunter R, Strickland F, Kezdy F,. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance. J Immunol 1981; 127: 1244-1250.
131. Hunter RL, Bennett B,. The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers. J Immunol 1984; 133: 3167-3175.
132. Hunter RL, Bennett B,. The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces. Scand J Immunol 1986; 23: 287-300.
133. Zhou F, Yuan L, Li D, Huang H, Sun T, Chen H,. Cell adhesion on chiral surface: The role of protein adsorption. Colloids Surf B Biointerfaces 2012; 90: 97-101.
134. Dewez JL, Doren A, Schneider YJ, Rouxhet PG,. Competitive adsorption of proteins: Key of the relationship between substratum surface properties and adhesion of epithelial cells. Biomaterials 1999; 20: 547-559.
135. Oji MO, Wood JV, Downes S,. Effects of surface-treated cpTi and Ti6Al4V alloy on the initial attachment of human osteoblast cells. J Mater Sci Mater Med 1999; 10: 869-872.
136. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F,. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 2006; 8: 1859-1865.
137. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H,. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002; 277: 15107-15112.
138. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK,. Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277: 15028-15034.
139. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, Beg AA,. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001; 166: 7128-7135.
140. Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ, Jang E, Lee HA, Youn J, Akira S, Lee MS. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity 2007; 27: 321-333.
141. Curtin JF, Liu N, Candolfi M, Xiong W, Assi H, Yagiz K, Edwards MR, Michelsen KS, Kroeger KM, Liu C, Muhammad AK, Clark MC, Arditi M, Comin-Anduix B, Ribas A, Lowenstein PR, Castro MG. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 2009; 6: e10.
142. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006; 290: C917-C924.
143. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E,. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377.
144. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H,. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006; 26: 174-179.
145. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Grone HJ, Schaefer L. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009; 284: 24035-24048.
146. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, Malle E, Schaefer RM, Gröne HJ. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005; 115: 2223-2233.
147. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR,. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006; 177: 1272-1281.
148. Gariboldi S, Palazzo M, Zanobbio L, Selleri S, Sommariva M, Sfondrini L, Cavicchini S, Balsari A, Rumio C,. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol 2008; 181: 2103-2110.
149. Cheng N, He R, Tian J, Ye PP, Ye RD,. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 2008; 181: 22-26.
150. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D,. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004; 279: 12542-12550.
151. Ohashi K, Burkart V, Flohe S, Kolb H,. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164: 558-561.
152. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira J-P, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Ándre F, Delaloge S, Tursz T, Kroemer G, Zitrogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-1059.
153. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL,. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007; 282: 18265-18275.
154. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC,. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111.
155. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL,. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004; 279: 17079-17084.
156. Johnson GB, Brunn GJ, Kodaira Y, Platt JL,. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168: 5233-5239.
157. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, Brennan F, Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009; 15: 774-780.
158. Hodgkinson CP, Laxton RC, Patel K, Ye S,. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 2008; 28: 2275-2281.
159. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M,. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168: 5989-5992.
160. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002; 298: 1025-1029.
161. Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A,. Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 2008; 83: 1174-1180.
162. Ji Y, Liu J, Wang Z, Liu N,. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 2009; 23 (4-6): 265-276.
163. Smiley ST, King JA, Hancock WW,. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894.
164. Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M, Liao X, Billiar T, Xu J, Esmon CT, Tsung A. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011; 54: 999-1008.